A groundbreaking $3.9 million grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has been awarded to a consortium spearheaded by Sanford Burnham Prebys Medical Discovery Institute. This pivotal funding aims to propel the development of a novel non-opioid therapeutic for pain management, advancing it toward a Phase 1 clinical trial. The research initiative is helmed by Steven H…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.